Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Taxes on Income (Tables)

v3.22.1
Taxes on Income (Tables)
12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
Schedule of the domestic and foreign components
    Year ended December 31,  
    2021     2020     2019  
                   
Domestic   $ (58,092 )   $ (15,625 )   $ (25,607 )
Foreign    
-
     
-
     
-
 
                         
Total   $ (58,092 )   $ (15,625 )   $ (25,607 )

Schedule of the reconciliation of the income tax benefit
    Year ended December 31,  
    2021     2020     2019  
                   
Loss before income taxes, as reported in the consolidated statements of operations   $ 58,092     $ 15,625     $ 25,607  
Statutory tax rate     23 %     23 %     23 %
                         
Income tax benefit at statutory tax rate   $ (13,361 )   $ (3,594 )   $ (5,890 )
Non-deductible expenses     6,096       358       156  
Remeasurement of deferred taxes from currency exchange     209       (1,093 )     (444 )
Change in valuation allowance     7,023       4,316       6,162  
Effect of other non-deductible differences     33       13       16  
                         
Reported income taxes benefit   $
-
    $
-
    $
-
 

 

Schedule of the deferred tax assets
    December 31  
    2021     2020  
Deferred tax assets:            
    Net operating loss carry forwards   $ 16,241     $ 11,201  
    Research and development     5,165       3,394  
    Employees and payroll accrual     365       176  
    Property and equipment     61       38  
                 
Total deferred tax assets     21,832       14,809  
                 
Valuation allowance     (21,832 )     (14,809 )
                 
Deferred tax assets, net of valuation allowance   $
-
    $
-